Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, MJ; Park, JO; Hochhauser, D; Arnold, D; Oh, DY; Reinacher-Schick, A; Tortora, G; Algul, H; O'Reilly, EM; McGuinness, D; Cui, KY; Schlienger, K; Locker, GY; Kindler, HL

Golan, T (reprint author), Tel Aviv Univ, Sheba Med Ctr, Oncol Inst, IL-52621 Tel Aviv, Israel.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (4): 317

Abstract

BackgroundPatients with a germline BRCA1 or BRCA2 mutation make up a small subgroup of those with metastatic pancreatic cancer. The poly(adenosine dip......

Full Text Link